In pancreatic cancer, Cao et al. found that the P4HA1-HIF1α loop acted as a crucial regulator in glycolysis and oncogenesis and might serve as a promising therapy target [17]. This evidence concerns the gene P4HA1 and familial pancreatic carcinoma.